[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] Diabetic Diabetes Experts use pump

I got this from the Islet foundation message board.
Might be goo fodder for arguments when getting the pump.     Curtis Lomax

MiniMed: Diabetes Experts Know The Best Kept Secret in Medicine
Recent Survey Reveals Information Disconnect Between Healthcare Practitioners
and Patients

LARCHMONT, N.Y.--(BW HealthWire)--May 22, 2000--A survey published today in a
leading diabetes professional publication revealed that diabetes specialists
treat their own diabetes very differently from the average diabetes patient.

The study reveals a wide gap in the quality of care between the average diabetes
patient and a doctor or nurse with diabetes.

The survey published in Diabetes Educator (May/June 2000), titled, ``How
Diabetes Specialists Treat Their Own Diabetes: Findings From a Study of the AADE
and ADA Membership,'' was conducted by an independent research organization to
study how diabetes specialists, who have diabetes, manage their own care. More
than 50 percent of the doctors and nurses with diabetes reported using insulin
pumps rather than traditional syringe therapy.

The survey reported healthcare professionals using insulin pump therapy is
nearly ten times higher than the rate in which the average Type 1 diabetics use
this treatment. The study concluded that better knowledge of the latest studies,
past experience with controlling glycemic levels, and easier access to diabetes
specialists contributed to the dramatic difference.

``This study proves a huge disconnect in the medical community. As doctors, we
have the ability to give diabetes patients the power to keep themselves much
healthier with the current standard of diabetes treatment,'' said Dr. Michael
Perley, an endocrinologist with Type 1 diabetes.

``It is critical that healthcare systems and general practitioners, who treat
most of the diabetics in this country, take steps to educate their patients
about the importance of tight glycemic control and the various treatment options
available to them including insulin pump therapy.''

Type 1 diabetes, also known as insulin dependent diabetes, affects approximately
1 million people in the United States. Most Type 1 diabetics are diagnosed as
children or young adults. As an autoimmune disease, Type 1 diabetes leaves the
body unable to produce insulin -- the hormone crucial for proper body

The insulin pump, about the size of a pager, is designed to function almost like
the human pancreas, delivering insulin in small amounts throughout the day.

The benefits of insulin pump therapy include: improved blood sugar control
during play, work or sleep, increased lifestyle flexibility and a lower risk of
long-term complications including blindness and neuropathy, often resulting in

In the study, approximately 12,525 surveys were distributed to all professional
members of the American Association of the Diabetes Educators (AADE) and the
American Diabetes Association (ADA), with instructions for the survey to be
completed by only those individuals with diabetes. Of the 12,525 surveys, 802
were returned.

The prevalence of Type 1 diabetes in this sample was estimated to be higher than
that of the general U.S. population. Of the respondents with Type 1 diabetes, 96
percent practiced intensive treatment regimens.

Intensive management is defined as three or more shots per day or use of an
insulin pump. In the general population less than 25 percent of people with Type
1 diabetes practice intensive therapy.

The survey confirmed that diabetes specialists treat their own diabetes
according to current standards of medical care as recommended by the American
Diabetes Association -- with insulin pumps being the preferred method of insulin
therapy for Type 1 diabetes in this sample. The study implies that the average
diabetes patient and their doctors -- are unaware of the current standard of
care in America.

``As a physician with Type 1 diabetes, I am an advocate of tight glycemic
control and believe that insulin pump therapy should be the first line of
treatment for this form of the disease,'' said Dr. Perley.

``This study proves that is incumbent upon the diabetic patient to communicate
concerns about their disease and its effects on their life to their doctors and
nurses. Hopefully, we can narrow the communications gap between doctor and

Insulin pump therapy has been available since the 1980s as an optional treatment
for Type 1 diabetes. MiniMed in Sylmar, California, is the leading insulin pump
manufacturer in the United States. Insulin pumps are prescribed by a physician
and are supported by comprehensive training for the patient by a skilled

for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml